Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.7 USD | -4.64% | +10.37% | +67.78% |
Jun. 04 | Oppenheimer Initiates Cartesian Therapeutics With Outperform Rating, $50 Price Target | MT |
May. 24 | Mizuho Securities Starts Cartesian Therapeutics With Buy Rating | MT |
- Stock Market
- Equities
- RNAC Stock
- News Cartesian Therapeutics, Inc.